| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REVIEWS |
Bioengineering Department, University of Washington, Seattle, Washington.
Correspondence to Dr. Cecilia M. Giachelli, Bioengineering Department, Box 351720, University of Washington, Okanogan Lane, Bagley Hall, Seattle, WA 98195. Phone: 206-543-0205; Fax: 206-616-9763; E-mail: ceci{at}u.washington.edu
Vascular calcification is highly correlated with cardiovascular disease mortality, especially in patients with ESRD or diabetes. In addition to the devastating effects of inappropriate biomineralization seen in cardiac valvulopathies, calciphylaxis, and idiopathic arterial calcification, vascular calcification is now recognized as a marker of atherosclerotic plaque burden as well as a major contributor to loss of arterial compliance and increased pulse pressure seen with age, diabetes, and renal insufficiency. In recent years, several mechanisms to explain vascular calcification have been identified including (1) loss of inhibition, (2) induction of bone formation, (3) circulating nucleational complexes, and (4) cell death. Alterations in calcium (Ca) and phosphorus (P) balance as seen in patients with ESRD promotes vascular calcification via multiple mechanisms and may explain the alarmingly high levels of cardiovascular disease deaths in these patients. Strategies to control Ca and P levels in patients with ESRD have met with early success in preventing progression of vascular calcification. Whether or not vascular calcification can be reversed is not yet known, but exciting new studies suggest that this may be possible in the future.
This article has been cited by other articles:
![]() |
M. Pazianas, A. B. Rossebo, T. R. Pedersen, Y. A. Kesaniemi, and C. M. Otto Calcific Aortic Stenosis N. Engl. J. Med., January 1, 2009; 360(1): 85 - 86. [Full Text] [PDF] |
||||
![]() |
M. Rodriguez-Garcia, C. Gomez-Alonso, M. Naves-Diaz, J. B. Diaz-Lopez, C. Diaz-Corte, J. B. Cannata-Andia, and the Asturias Study Group Vascular calcifications, vertebral fractures and mortality in haemodialysis patients Nephrol. Dial. Transplant., January 1, 2009; 24(1): 239 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cseprekal, E. Kis, P. Schaffer, T. E. H. Othmane, B. Cs. Fekete, A. Vannay, A. J. Szabo, A. Remport, A. Szabo, T. Tulassay, et al. Pulse wave velocity in children following renal transplantation Nephrol. Dial. Transplant., January 1, 2009; 24(1): 309 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Noonan, K. Koch, M. Nakane, J. Ma, D. Dixon, A. Bolin, and G. Reinhart Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3824 - 3830. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Honkanen, L. Kauppila, B. Wikstrom, P. L. Rensma, J.-M. Krzesinski, K. Aasarod, F. Verbeke, P. B. Jensen, P. Mattelaer, B. Volck, et al. Abdominal aortic calcification in dialysis patients: results of the CORD study Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4009 - 4015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-u. Alam, J. P. Kirton, F. L. Wilkinson, E. Towers, S. Sinha, M. Rouhi, T. N. Vizard, A. P. Sage, D. Martin, D. T. Ward, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells Cardiovasc Res, November 6, 2008; (2008) cvn279v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Speer, B. Cs. Fekete, T. El Hadj Othmane, T. Szabo, J. Egresits, E. Fodor, I. Kiss, A. G. Logan, J. Nemcsik, A. Szabo, et al. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3256 - 3262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn502v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Mandelbrot, P. W. Santos, R. K. Burt, Y. Oyama, G. A. Block, S. N. Ahya, R. M. Rosa, and A. E. Traynor Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2679 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wollina, C. Helm, G. Hansel, A. Koch, J. Schonlebe, G. Haroske, and E. Kostler Deep Ulcer Shaving Combined With Split-Skin Transplantation in Distal Calciphylaxis International Journal of Lower Extremity Wounds, June 1, 2008; 7(2): 102 - 107. [Abstract] [PDF] |
||||
![]() |
J. D. Morrisett and K. C. Vickers Vascular Calcification in Homozygote Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 606 - 607. [Full Text] [PDF] |
||||
![]() |
Z. Awan, K. Alrasadi, G.A. Francis, R.A. Hegele, R. McPherson, J. Frohlich, D. Valenti, B. de Varennes, M. Marcil, C. Gagne, et al. Vascular Calcifications in Homozygote Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 777 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, H. Sato, H. Doi, C. A. Yoshida, T. Shimizu, H. Matsui, M. Yamazaki, H. Akiyama, K. Kawai-Kowase, T. Iso, et al. Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells Mol. Cell. Biol., February 1, 2008; 28(3): 1147 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Andress Bone and Mineral Guidelines for Patients with Chronic Kidney Disease: A Call for Revision Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 179 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1592 - F1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Voormolen, M. Noordzij, D. C. Grootendorst, I. Beetz, Y. W. Sijpkens, J. G. van Manen, E. W. Boeschoten, R. M. Huisman, R. T. Krediet, F. W. Dekker, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2909 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Molostvov, S. James, S. Fletcher, J. Bennett, H. Lehnert, R. Bland, and D. Zehnder Extracellular calcium-sensing receptor is functionally expressed in human artery Am J Physiol Renal Physiol, September 1, 2007; 293(3): F946 - F955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ix, G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study Circulation, May 15, 2007; 115(19): 2533 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Meng, I. Vera, N. Che, X. Wang, S. S. Wang, L. Ingram-Drake, E. E. Schadt, T. A. Drake, and A. J. Lusis Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics PNAS, March 13, 2007; 104(11): 4530 - 4535. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Gross, H.-P. Meyer, H. Ziebart, P. Rieger, U. Wenzel, K. Amann, I. Berger, M. Adamczak, P. Schirmacher, and E. Ritz Calcification of Coronary Intima and Media: Immunohistochemistry, Backscatter Imaging, and X-Ray Analysis in Renal and Nonrenal Patients Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 121 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. X. Chen, D. Duan, K. D. O'Neill, and S. M. Moe High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3435 - 3442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Rakhit, T H Marwick, K A Armstrong, D W Johnson, R Leano, and N M Isbel Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease Heart, October 1, 2006; 92(10): 1402 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wu-Wong, W. Noonan, J. Ma, D. Dixon, M. Nakane, A. L. Bolin, K. A. Koch, S. Postl, S. J. Morgan, and G. A. Reinhart Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bushinsky Phosphate Binders: Hold the Calcium? Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 695 - 696. [Full Text] [PDF] |
||||
![]() |
D. Yuen, A. Pierratos, R. M.A. Richardson, and C. T. Chan The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1407 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Demer and Y. Tintut Pitting Phosphate Transport Inhibitors Against Vascular Calcification Circ. Res., April 14, 2006; 98(7): 857 - 859. [Full Text] [PDF] |
||||
![]() |
C. P. Schmitt, T. Odenwald, and E. Ritz Calcium, Calcium Regulatory Hormones, and Calcimimetics: Impact on Cardiovascular Mortality J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S78 - S80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Williams Coronary Revascularization in Diabetic Chronic Kidney Disease/End-Stage Renal Disease: A Nephrologist's Perspective Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 209 - 220. [Full Text] [PDF] |
||||
![]() |
I. Lopez, E. Aguilera-Tejero, F. J. Mendoza, Y. Almaden, J. Perez, D. Martin, and M. Rodriguez Calcimimetic R-568 Decreases Extraosseous Calcifications in Uremic Rats Treated with Calcitriol J. Am. Soc. Nephrol., March 1, 2006; 17(3): 795 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ketteler, V. Brandenburg, W. Jahnen-Dechent, R. Westenfeld, and J. Floege Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse Nephrol. Dial. Transplant., April 1, 2005; 20(4): 673 - 677. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673